Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
März, W; Gross, W; Gahn, G; Romberg, G; Taubert, HD; Kuhl, H.
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Am J Obstet Gynecol. 1985; 153(3):287-293
Doi: 10.1016/S0002-9378(85)80114-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The effect of a triphasic combination of ethinyl estradiol and levonorgestrel upon various lipoprotein parameters was compared to that of a preparation that contained ethinyl estradiol and desogestrel on days 6, 11, 21, and 28 of a control cycle, the third cycle of treatment with either ethinyl estradiol/levonorgestrel or ethinyl estradiol/desogestrel (11 volunteers each), the third cycle of a 3-month washout period, and the third treatment cycle after crossover change of the preparations. Significant increases were found in total triglycerides (15% to 20%) and phospholipids (8%) with both preparations, whereas total cholesterol and lipoprotein Lp(a) were not altered. High-density lipoprotein triglycerides (50% to 60%) and high-density lipoprotein-3 cholesterol (10% to 15%) were elevated by both contraceptives, high-density lipoprotein cholesterol and alpha-lipoprotein cholesterol only by ethinyl estradiol/desogestrel (11%), whereas high-density lipoprotein phospholipids, high-density lipoprotein-2 phospholipids, high-density lipoprotein-3 phospholipids, and high-density lipoprotein-2 cholesterol were not influenced. Both ethinyl estradiol/levonorgestrel and ethinyl estradiol/desogestrel increased apolipoproteins A (14%), A-I (20% to 30%), and A-II (25% to 35%) significantly. Very low-density lipoprotein triglycerides were elevated (30%) only by ethinyl estradiol/desogestrel, and low-density lipoprotein phospholipids (20%) by both ethinyl estradiol/levonorgestrel and ethinyl estradiol/desogestrel, whereas the other parameters, very low-density lipoprotein phospholipids, very low-density lipoprotein cholesterol, pre-beta-lipoprotein cholesterol, low-density lipoprotein triglycerides, low-density lipoprotein cholesterol, beta-lipoprotein cholesterol, and apolipoprotein B, were not significantly changed. Provided that the assumption is correct that high low-density lipoprotein cholesterol and apolipoprotein B and low high-density lipoprotein subfractions and apolipoprotein A are associated with an elevated risk of atherosclerosis, the results seem to represent beneficial rather than deleterious side effects of the low-dose oral contraceptives.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Apolipoproteins A - blood
- Apolipoproteins B - blood
- Cholesterol - blood
- Cholesterol, HDL - blood
- Cholesterol, LDL - blood
- Contraceptives, Oral, Combined - pharmacology
- Desogestrel - pharmacology
- Ethinyl Estradiol - pharmacology
- Female - pharmacology
- Humans - pharmacology
- Levonorgestrel - pharmacology
- Lipids - blood
- Lipoproteins - blood
- Lipoproteins, HDL - blood
- Lipoproteins, VLDL - blood
- Norgestrel - pharmacology
- Norpregnenes - pharmacology
- Phospholipids - blood
- Random Allocation - blood
- Triglycerides - blood